Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 156 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1551 6.9 months GBM (recurrent) Chemotherapy
University of Tubingen Germany 2/2005
Treatment Details: Patients: This trial involved 10 patients with relapsed glioblastoma. There were 4 men and 6 women, and the median age was 45. Treatment: The treatment consisted of two chemotherapeuti
 
1552 6.9 months NSCLC 4 Chemotherapy
Rush University Medical Center United States 5/2008
Treatment Details: Patients: This phase III study involved 849 patients with non-small-cell lung cancer. The majority of patients (over 70%) were men, and they ranged in age from 30 to 87 years of age.
 
1553 6.9 months Recurrent GBM 5 Biologic therapy
Chemotherapy
MD Anderson Cancer Center United States 6/2008
Treatment Details: Patients: This phase 2 study involved 43 patients with recurrent glioblastoma. There were 28 men and 15 women. The median age was 53, ranging from 23 to 71 years old. They had all been t
 
1554 6.9 months Platinum resistant ovarian cancer 4 Chemotherapy
Mount Vernon Cancer Centre United Kingdom 3/2011
Treatment Details: Patients: This phase 2 trial involved women with ovarian cancer that had progressed following prior platinum-based chemotherapy. Patients were divided into two treatment groups. Group A c
 
1555 6.9 months Recurrent GBM 5 Biologic therapy
Chemotherapy
Copenhagen University Hospital Denmark 5/2010
Treatment Details: Patients: This study involved 43 patients with recurrent primary glioblastoma multiforme. The median age of the group was 54 years and 58% were male. Treatment: Patients were treated w
 
1556 6.9 months Transitional cell carcinoma of the urothelial tract 5 Chemotherapy
University Hospital Del Mar Spain 9/2009
Treatment Details: Patients: This phase III study involved 253 patients with a type of bladder cancer called transitional cell carcinoma of the urothelial tract. Patients had received prior platinum-containi
 
1557 6.9 months NHL 4 Chemotherapy
The University of Texas M. D. Anderson Cancer Center United States 8/2009
Treatment Details: Patients: This phase II study involved 119 non-Hodgkin’s lymphoma patients with a median age of 60 years; 54% were male. Treatment: Patients were treated a drug called Marqibo, which is
 
1558 6.9 months GBM 2 Radiation
University of Wisconsin United States 3/2014
Treatment Details: Patients: This study involved 23 glioblastoma patients who had been previously treated with bevacizumab (a biologic therapy). The median patient age was 53 years and 52% were male. Trea
 
1559 6.9 months Hepatocellular carcinoma 3 Biologic therapy
Radiation
East Carolina University United States 12/2013
Treatment Details: Patients: This study involved 10 hepatocellular carcinoma patients with an average age of 63.5 years, 8 of whom were male. Treatment: Patients were treated with a form of radiation the
 
1560 6.9 months GBM 5 Biologic therapy
Brigham and Women's Hospital United States 1/2015
Treatment Details: Patients: This phase 2 study involved high-grade glioma (glioblastoma or anaplastic glioma) patients who were divided into groups based on prior treatment. Group A consisted of 22 patients
 
Page 156 of 187  | Previous Page  | Next Page